chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Computerised tomogram thorax abnormal, Cough, Fatigue, Headache, Lung consolidation
Clinical narrative: Narrative: COVID infection following COVID vaccine series and after previous COVID infection 01/14, Pfizer, dose #1 02/04, Pfizer dose #2 08/04 pt cc: cough, rhinorrhea, fatigue, headache, myalgias, nocturnal dyspnea exposure: unknown 08/05 COVID swab, result: detected 08/05 - 08/12 pt's symptoms continued 08/05 CXR impression: Chronic right pleural effusion and atelectatic changes in the right lung base, stable from previous examination. The remaining visualized lung fields are clear. 08/09 pt admitted in ED dx: COVID PNA LOS: 1 day 08/09 TROPONIN I 0.120 08/09 BNP 2251 08/09 CXR impression: The heart shadow is normal in size. Small right pleural effusion and adjacent atelectasis/consolidation is stable from prior. No new consolidation or pneumothorax. Note that groundglass opacities, as can occur with viral pneumonia, may not be visible on plan film 08/10 CT Chest impression: Scattered bilateral patchy groundglass opacities and groundglass nodules, left greater than right, can be seen in COVID-19 pneumonia. Small right pleural effusion. Mildly progressive right middle lobe consolidation. Recommend follow-up. 08/12 Clinically resolved 08/12 SARS-COV-2 LINGEAGE result: B.1.617.2 08/12 SARS-COV-2 clade results: 21A DELTA 08/26 COVID swab, result detected
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Lung opacity, Malaise, Myalgia, Nocturnal dyspnoea, Pleural effusion
Clinical narrative: Narrative: COVID infection following COVID vaccine series and after previous COVID infection 01/14, Pfizer, dose #1 02/04, Pfizer dose #2 08/04 pt cc: cough, rhinorrhea, fatigue, headache, myalgias, nocturnal dyspnea exposure: unknown 08/05 COVID swab, result: detected 08/05 - 08/12 pt's symptoms continued 08/05 CXR impression: Chronic right pleural effusion and atelectatic changes in the right lung base, stable from previous examination. The remaining visualized lung fields are clear. 08/09 pt admitted in ED dx: COVID PNA LOS: 1 day 08/09 TROPONIN I 0.120 08/09 BNP 2251 08/09 CXR impression: The heart shadow is normal in size. Small right pleural effusion and adjacent atelectasis/consolidation is stable from prior. No new consolidation or pneumothorax. Note that groundglass opacities, as can occur with viral pneumonia, may not be visible on plan film 08/10 CT Chest impression: Scattered bilateral patchy groundglass opacities and groundglass nodules, left greater than right, can be seen in COVID-19 pneumonia. Small right pleural effusion. Mildly progressive right middle lobe consolidation. Recommend follow-up. 08/12 Clinically resolved 08/12 SARS-COV-2 LINGEAGE result: B.1.617.2 08/12 SARS-COV-2 clade results: 21A DELTA 08/26 COVID swab, result detected
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Rhinorrhoea, SARS-CoV-2 test, SARS-CoV-2 test positive, Troponin I normal
Clinical narrative: Narrative: COVID infection following COVID vaccine series and after previous COVID infection 01/14, Pfizer, dose #1 02/04, Pfizer dose #2 08/04 pt cc: cough, rhinorrhea, fatigue, headache, myalgias, nocturnal dyspnea exposure: unknown 08/05 COVID swab, result: detected 08/05 - 08/12 pt's symptoms continued 08/05 CXR impression: Chronic right pleural effusion and atelectatic changes in the right lung base, stable from previous examination. The remaining visualized lung fields are clear. 08/09 pt admitted in ED dx: COVID PNA LOS: 1 day 08/09 TROPONIN I 0.120 08/09 BNP 2251 08/09 CXR impression: The heart shadow is normal in size. Small right pleural effusion and adjacent atelectasis/consolidation is stable from prior. No new consolidation or pneumothorax. Note that groundglass opacities, as can occur with viral pneumonia, may not be visible on plan film 08/10 CT Chest impression: Scattered bilateral patchy groundglass opacities and groundglass nodules, left greater than right, can be seen in COVID-19 pneumonia. Small right pleural effusion. Mildly progressive right middle lobe consolidation. Recommend follow-up. 08/12 Clinically resolved 08/12 SARS-COV-2 LINGEAGE result: B.1.617.2 08/12 SARS-COV-2 clade results: 21A DELTA 08/26 COVID swab, result detected
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Blood test normal, Chest discomfort, Chest pain, Computerised tomogram thorax abnormal, Electrocardiogram normal
Clinical narrative: Narrative: A 64yo male with no known PMH who flew in from the previous week, presented to the ED with Chief complain of body rash and some chest pain, on July 6, 2021 ED physician's documentation indicated the patient reported he had J&J Covid-19 vaccine on June 23, 2021 and had an intermittent body rash accompanied by itching on various parts of his body. Addionally he reported having three episodes of chest pain described as "pressure" Physician's A/P included the rash was a possible reaction to the vaccine and was treated with Solumedrol 125mg iv and famotidine 20mg Elevated D-dimer and CT scan were concerning for a mass in his right lung, which were discussed with the patient for further testing and recommendations by the physcian EKG and Blood work were also checked prior to discharge and there was no evidence of PE HIs discharge medications included Medrol dosepak, famotidine 20mg by mouth twice a day and topical hydropcortisone 2.5% sparingly to the affected area twice a day On July 8, 2021 the patient returned to the ED with chief complain of generalized unrelieved itching and was concerned due to a return flight of travel, the following day. Benadryl 25mg three times a day as needed was added to his discharge medication regimen, famotidine dose was increased to 40 mg twice a day and Prednisone tapering over 14 days
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Fibrin D dimer increased, Pruritus, Rash
Clinical narrative: Narrative: A 64yo male with no known PMH who flew in from the previous week, presented to the ED with Chief complain of body rash and some chest pain, on July 6, 2021 ED physician's documentation indicated the patient reported he had J&J Covid-19 vaccine on June 23, 2021 and had an intermittent body rash accompanied by itching on various parts of his body. Addionally he reported having three episodes of chest pain described as "pressure" Physician's A/P included the rash was a possible reaction to the vaccine and was treated with Solumedrol 125mg iv and famotidine 20mg Elevated D-dimer and CT scan were concerning for a mass in his right lung, which were discussed with the patient for further testing and recommendations by the physcian EKG and Blood work were also checked prior to discharge and there was no evidence of PE HIs discharge medications included Medrol dosepak, famotidine 20mg by mouth twice a day and topical hydropcortisone 2.5% sparingly to the affected area twice a day On July 8, 2021 the patient returned to the ED with chief complain of generalized unrelieved itching and was concerned due to a return flight of travel, the following day. Benadryl 25mg three times a day as needed was added to his discharge medication regimen, famotidine dose was increased to 40 mg twice a day and Prednisone tapering over 14 days
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Narrative: Patient developed injection site pain following administration of Pfizer Covid vaccine dose 2. Patient required no intervention and was able to leave following normal monitoring period.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Narrative: Patient reported injection site pain following administration of 2nd dose of Pfizer covid vaccine. Patient required no intervention and was able to leave following normal monitoring period.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Narrative: Patient reported lightheadedness following administration of Pfizer COVID-19 vaccine. Patient required no intervention and was able to leave following normal monitoring period.
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Hypertension
Clinical narrative: Narrative: Patient reported developing headache and high blood pressure following administration of second dose of Pfizer Covid Vaccine. Resolved without intervention.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness postural, Headache, Impaired work ability, Nausea
Clinical narrative: Narrative: Patient c/o of onset of headache, nausea today after 2nd Pfizer covid vaccine. Reported dizziness as she stood to ambulate to exam area. Pt reported this happened after 1st dose and was unable to work for 2 days after. Patient was monitored for another 15 minutes however was still dizzy upon standing. Patient was strongly recommended by physician assistant to go to ER via ambulance. However patient left AMA. Patient was able to make her primary care appointment 2 hours later.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Condition aggravated
Clinical narrative: Narrative: Patient with history of anxiety developed anxiety following Pfizer Covid Vaccine dose.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: Narrative: Patient developed pruritus following administration of Pfizer covid vaccine.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Blood pressure increased, Headache
Clinical narrative: Narrative: Patient developed headache and elevated BP. Patient did not require any additional intervention and was able to able to leave following normal monitoring period.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Pain in extremity
Clinical narrative: Narrative: Patient reported arm and joint pain the opposite arm of the injection following administration of 1st dose of Pfizer Covid Vaccine. Patient states it started 1 day post vaccination and continued for several days.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Headache
Clinical narrative: Narrative: Patient reported headache and light headedness following administration of Pfizer covid vaccine. Patient reported recurrence of this following second dose of Pfizer covid vaccine. Patient was monitored without additional intervention and was able to depart.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Narrative: Patient reported lightheadedness following second dose of pfizer covid vaccine. Patient's vitals were taken and were within normal limits. Patient was able to be released with no additional intervention.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Hypotension, Loss of consciousness, Pulse absent
Clinical narrative: Narrative: Patient became hypotensive, lost consciousness and pulse for about 20 seconds, Paramedics were contacted and patient was taken to outside emergency department for management.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Hypersensitivity, Hypotension, Tachycardia, Urticaria
Clinical narrative: Narrative:  Patient is a 55yo FEMALE with PMH significant for breast cancer, hypothyroidism, and PTSD. In addition, patient with significant adverse reaction/allergy history. Causative agents include medications (e.g., penicillin [rash], codeine [N/V, rash], acyclovir [anaphylaxis], valacyclovir [rash, angioedema] and non-medication triggers (e.g., gluten [anaphylaxis], wasp venom [anaphylaxis], bee pollen [anaphylaxis], contrast media [swelling]). Per 2/23/21 Clinic Video Visit note, patient received the first dose of the Pfizer COVID-19 vaccine on 1/7/21 at a outside facility. Patient had a delayed allergic reaction involving hives, hypotension, and tachycardia. The reaction may have been delayed due to patient pre-medicating with diphenhydramine prior to receiving the vaccine. Patient elected to not have the second dose of the vaccine and may reconsider in the future. No further notes documenting further adverse effects from the vaccine.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Narrative: Unclear of reaction the patient experienced. Documented as "internal shingles" requiring management in the emergency department following administration of 1st dose of Moderna covid vaccine. This was at an outside ED as no additional information is available regarding the nature of the reaction or any treatments that were administered to manage the reaction.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Narrative: Patient reported injection site pain following administration of 1st dose of Pfizer Covid vaccine. Resolved without intervention.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea
Clinical narrative: Narrative: Patient reported nausea and headache following administration of pfizer covid vaccine. Patient required no intervention and was able to depart with no issue.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Hypoaesthesia
Clinical narrative: Narrative: Patient reported numbness in lower extremities and dizziness while siting. No additional information provided. Patient did not require additional intervention or follow up.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Hot flush, Lethargy
Clinical narrative: Narrative: Patient reported dizziness, hot flashes, and lethargy following administration of Moderna covid vaccine. No interventions were provided to the patient and patient was able to be released.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Hot flush, Immediate post-injection reaction
Clinical narrative: Narrative: Patient reported flushing immediately after receiving their second dose of Pfizer covid vaccine. Patient reported it only lasted about 1 minute and did not need any intervention.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Dysphagia, Rhinorrhoea, Tearfulness, Throat tightness
Clinical narrative: Narrative: Patient reported runny nose, tearing, and mild difficulty swallowing, cough, and tightness in throat within 1 minute after administration of Pfizer covid vaccine. Abated over about 15 minutes. Patient was observed for 30 minutes by which point these adverse effects had completely resolved. Patient did not require any intervention.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Narrative: Patient reported feeling dizzy following administration of pfizer covid vaccine. Patient was observed for additional time before being released without any intervention.
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site pruritus
Clinical narrative: Narrative: Patient reported itching at the site of the injection of their 2nd dose of pfizer covid vaccine. Patient stated they had a similiar reaction following their 1st dose of vaccine. Patient did not need any intervention and was able to be released.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Anxiety, Chest pain, Electrocardiogram normal
Clinical narrative: Narrative: Patient reported chest pain shortly after administration of second dose of pfizer covid vaccine. NO EKG changes and pain laster about 15 minutes before resolution. Declined evaluation in the emergency department. Likely brought on by anxiety. Patient was released with no additional intervention
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Anxiety
Clinical narrative: Narrative: Patient reported anxiety after administration of 1st dose of Pfizer COVID vaccination. Patient required no intervention and was able to be released without issue.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Dizziness
Clinical narrative: Narrative: Unclear reaction. Patient reported chest tightness and dizziness and was taken to emergency department for evaluation. Those records are unavailable. Patient did receive second dose without issue so unlikely to have been an allergic reaction. Possibly panic/anxiety attack.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Narrative: Patient reported mild lightheadedness following administration of 1st dose of Pfizer Covid vaccine. Patient was released without any intervention needed.
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Narrative: Patient developed injection site pain following administration of second dose of Pfizer covid vaccine.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea
Clinical narrative: Narrative: Patient complained of difficult breathing following administration of 1st dose of covid vaccine. Patient with history of allergy to toradol. Patient verbalized without issue but O2 sats dropping to 93. Patient was transported to outside emergency department for evaluation.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Dry mouth, Throat irritation
Clinical narrative: Narrative: Patient reported sensation of dry mouth and scratchy throat following administration of 1st dose of Pfizer covid vaccine. Patient was able to be released with no intervention needed.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Hyperhidrosis
Clinical narrative: Narrative: Patient reported lightheadedness and diaphoresis following administration of their second dose of covid vaccine. Patient was able to be released with no additional intervention.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Dyspnoea
Clinical narrative: Narrative: Patient reported feeling short of breath and chest pain about a week following administration of 1st dose of pfizer vaccine. Patient was advised to seek emergency medical attention. Unclear if patient did, no outside notes documented. Patient did received second dose of pfizer covid vaccine without issue.
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Anxiety
Clinical narrative: Narrative: Patient developed anxiety following first dose of Moderna covid vaccine. Patient was given an ice pack and place to lay down with relief. Patient was able to depart with no additional interventions.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chills, Cough, Discharge, Eye pain
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 02/25, Pfizer, dose #1 03/18, Pfizer, dose #2 10/23/2020 Influenza administered 12/22/2020 COVID swab, result: detected 08/03 COVID swab, result: detected 08/04 pt cc: chills, cough, fever, rhinorrhea, sore throat exposure: " Was at restaurant: 08/05 pt cc: bilat eye redness, and itchiness for two days denies pain, loss of vision, trauma 08/06 pt cc: chills (improving), cough (improving), rhinorrhea (improving) "getting better" 08/07 pt cc: fatigue, fever (pt report temperature: 99.3) 08/08 pt cc: fatigue (improving), fever (improving), rhinorrhea (improving). 08/08 pt cc: possible bilat pink eye, sore eye, minimal drainage started (08/5) 08/09 pt cc: fatigue and rhinorrhea both improving 08/10 pt cc: no symptoms 08/10 clinically resolved 08/12 SARS-COV-2 Variant Sequencing result: pending
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Laboratory test, Ocular hyperaemia, Oropharyngeal pain, Pruritus
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 02/25, Pfizer, dose #1 03/18, Pfizer, dose #2 10/23/2020 Influenza administered 12/22/2020 COVID swab, result: detected 08/03 COVID swab, result: detected 08/04 pt cc: chills, cough, fever, rhinorrhea, sore throat exposure: " Was at restaurant: 08/05 pt cc: bilat eye redness, and itchiness for two days denies pain, loss of vision, trauma 08/06 pt cc: chills (improving), cough (improving), rhinorrhea (improving) "getting better" 08/07 pt cc: fatigue, fever (pt report temperature: 99.3) 08/08 pt cc: fatigue (improving), fever (improving), rhinorrhea (improving). 08/08 pt cc: possible bilat pink eye, sore eye, minimal drainage started (08/5) 08/09 pt cc: fatigue and rhinorrhea both improving 08/10 pt cc: no symptoms 08/10 clinically resolved 08/12 SARS-COV-2 Variant Sequencing result: pending
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 02/25, Pfizer, dose #1 03/18, Pfizer, dose #2 10/23/2020 Influenza administered 12/22/2020 COVID swab, result: detected 08/03 COVID swab, result: detected 08/04 pt cc: chills, cough, fever, rhinorrhea, sore throat exposure: " Was at restaurant: 08/05 pt cc: bilat eye redness, and itchiness for two days denies pain, loss of vision, trauma 08/06 pt cc: chills (improving), cough (improving), rhinorrhea (improving) "getting better" 08/07 pt cc: fatigue, fever (pt report temperature: 99.3) 08/08 pt cc: fatigue (improving), fever (improving), rhinorrhea (improving). 08/08 pt cc: possible bilat pink eye, sore eye, minimal drainage started (08/5) 08/09 pt cc: fatigue and rhinorrhea both improving 08/10 pt cc: no symptoms 08/10 clinically resolved 08/12 SARS-COV-2 Variant Sequencing result: pending
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, COVID-19, Cough, Rhinorrhoea
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/04, Pfizer, dose #1 03/25, Pfizer, dose #2 08/04 COVID swab, result: detected 08/05 pt cc: cough, rhinorrhea, loss of taste or smell exposure; unknow 08/08 clinically resolved.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/04, Pfizer, dose #1 03/25, Pfizer, dose #2 08/04 COVID swab, result: detected 08/05 pt cc: cough, rhinorrhea, loss of taste or smell exposure; unknow 08/08 clinically resolved.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Lethargy, Nausea, Pain in extremity, Pyrexia, Vomiting
Clinical narrative: Fever, NauseaVomiting, arm pain, lethargic Narrative:
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Pharyngeal swelling, Throat irritation
Clinical narrative: Narrative: Patient reported throat swelling and itching 4 hours following 1st dose of pfizer covid vaccine. Patient did not seek medical care nor did they take any medication to manage these symptoms and this feeling passed. No other issues reported.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: Narrative: Patient reported diarrhea following 1st dose of Pfizer covid vaccine. Resolved without intervention.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Peripheral swelling
Clinical narrative: Narrative: Patient reported swelling of the arm they received their 1st dose of Pfizer Covid vaccine following injection. Patient reported it took nearly 2 weeks for the swelling to resolve. Did not report any interventions needed to manage the swelling.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Asthenia, Dizziness, Injection site hypoaesthesia, Injection site pain
Clinical narrative: Narrative: Patient reported injection site pain and numbness following administration of pfizer covid vaccine. The patient additionally reported anxiety, lightheadedness, dizziness, and weakness. The patient was observed for additional period with improvement. No intervention was needed and patient was able to released without issue.
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Throat irritation
Clinical narrative: Narrative: Patient reported throat itching that started before receiving the pfizer covid vaccine. This was likely not the result of the covid vaccine based on it starting before the vaccine.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Narrative: Patient reported lightheadedness and dizziness following administration of first dose of Pfizer covid vaccine. Patient was able to be released with no intervention.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Bronchitis, Dyspnoea
Clinical narrative: Narrative: Patient developed shortness of breath following second dose of pfizer covid vaccine. Patient went to urgent where she was diagnosed with bronchitis and given steroids and inhaler as treatment.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury
Clinical narrative: Narrative: Patient received 1st dose of Moderna vaccine. Patient was admitted to outside facility shortly thereafter for acutre renal failure. Unclear if result of vaccine or if patient was volume depleted. Outside records unavailable.
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Chest discomfort
Clinical narrative: Narrative:  Patient reported chest tightness following administration of Janssen covid vaccine. Patient was advised to seek medical care. Unclear whether patient did and if additional intervention was needed.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Pharyngeal swelling
Clinical narrative: Narrative: Patient reported throat swelling following administration of J&oJ covid vaccine requiring EPI-PEN injection which provided relief. Patient was transported to the ED via ambulance following administration of epi-pen.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Dry mouth, Paraesthesia oral
Clinical narrative: Narrative: Patient reported dry mouth and tingling around lips approximately 10 minutes following administration of Pfizer covid vaccine. This resolved. after about 30 minutes without intervention and patient was released
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Narrative: Patient reported injection site pain following administration of 1st dose of pfizer covid vaccine. Patient was released without any intervention.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Narrative: Patient reported injection site pain following administration of 1st dose of Pfizer covid vaccine. Patient was released with no additional intervention.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Narrative: Patient reported feeling faint after administration of 1st dose of covid vaccine. Patient was released with no additional intervention needed.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea
Clinical narrative: Narrative: Patient developed difficulty breathing approximately 3 minutes after administration of Janseen covid vaccine. Nurse administered Epi-Pen with patient reporting respiratory relief. Nurse did not report hives or tongue swelling. Patient was taken to the ER for further evaluation.
Age: 90.0
Sex: M
Vaccine: PNC13
Symptoms: Adverse reaction
Clinical narrative: Narrative:  Per 5/12/21 TELEPHONE NOTE, adverse vaccine reaction occurred for approximately 6 days following initial documentation in Patient's chart. No further complications documented following caregiver reported resolution.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Narrative:  Patient reported headache following administration of 2nd dose of pfizer vaccine. Patient released without intervention.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: Narrative:  Patient reported tingling sensation that started on left side and spread down torso shortly after administration of 1st dose of pfizer vaccine. Patient was able to depart without any intervention but stated symptoms did not resolve by time of departing.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Dry throat, Throat irritation
Clinical narrative: Narrative: Patient reported dry/scratchy throat following administration of 2nd dose of pfizer covid vaccine. Patient was able to depart without any intervention.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Activated partial thromboplastin time normal, Ageusia, Anosmia, COVID-19, Cough
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 03/09, Pfizer, dose #1 04/02, Pfizer, dose #2 08/03 pt cc: cough, diarrhea, cold like symptoms , headache exposure: "patient claims a lot of people from her work were positive for COVID19" 08/04 COVID swab, result: detected 08/05 pt cc: cough, diarrhea, fatigue, fever, headache, myalgias, sore throat 08/06 pt cc: cough, fever, myalgias 08/07 pt cc: cough, fatigue, loss of taste or smell symptoms are improving 08/08 pt cc: cough, fatigue symptoms are improving 08/11 pt cc: bilateral leg numbness 08/11 ED admission with cc: tingling in her extremities and face, fatigue, malaise 08/12 SARS COV-2 LINEAGE result: AY.4 08/12 SARS-COV-2 CLADE result: 21A Delta
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Electrocardiogram QT prolonged, Exposure to SARS-CoV-2, Fatigue, Headache
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 03/09, Pfizer, dose #1 04/02, Pfizer, dose #2 08/03 pt cc: cough, diarrhea, cold like symptoms , headache exposure: "patient claims a lot of people from her work were positive for COVID19" 08/04 COVID swab, result: detected 08/05 pt cc: cough, diarrhea, fatigue, fever, headache, myalgias, sore throat 08/06 pt cc: cough, fever, myalgias 08/07 pt cc: cough, fatigue, loss of taste or smell symptoms are improving 08/08 pt cc: cough, fatigue symptoms are improving 08/11 pt cc: bilateral leg numbness 08/11 ED admission with cc: tingling in her extremities and face, fatigue, malaise 08/12 SARS COV-2 LINEAGE result: AY.4 08/12 SARS-COV-2 CLADE result: 21A Delta
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, International normalised ratio normal, Laboratory test, Malaise, Myalgia
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 03/09, Pfizer, dose #1 04/02, Pfizer, dose #2 08/03 pt cc: cough, diarrhea, cold like symptoms , headache exposure: "patient claims a lot of people from her work were positive for COVID19" 08/04 COVID swab, result: detected 08/05 pt cc: cough, diarrhea, fatigue, fever, headache, myalgias, sore throat 08/06 pt cc: cough, fever, myalgias 08/07 pt cc: cough, fatigue, loss of taste or smell symptoms are improving 08/08 pt cc: cough, fatigue symptoms are improving 08/11 pt cc: bilateral leg numbness 08/11 ED admission with cc: tingling in her extremities and face, fatigue, malaise 08/12 SARS COV-2 LINEAGE result: AY.4 08/12 SARS-COV-2 CLADE result: 21A Delta
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Nasopharyngitis, Oropharyngeal pain, Paraesthesia, Prothrombin time normal, Pyrexia
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 03/09, Pfizer, dose #1 04/02, Pfizer, dose #2 08/03 pt cc: cough, diarrhea, cold like symptoms , headache exposure: "patient claims a lot of people from her work were positive for COVID19" 08/04 COVID swab, result: detected 08/05 pt cc: cough, diarrhea, fatigue, fever, headache, myalgias, sore throat 08/06 pt cc: cough, fever, myalgias 08/07 pt cc: cough, fatigue, loss of taste or smell symptoms are improving 08/08 pt cc: cough, fatigue symptoms are improving 08/11 pt cc: bilateral leg numbness 08/11 ED admission with cc: tingling in her extremities and face, fatigue, malaise 08/12 SARS COV-2 LINEAGE result: AY.4 08/12 SARS-COV-2 CLADE result: 21A Delta
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Troponin I normal
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 03/09, Pfizer, dose #1 04/02, Pfizer, dose #2 08/03 pt cc: cough, diarrhea, cold like symptoms , headache exposure: "patient claims a lot of people from her work were positive for COVID19" 08/04 COVID swab, result: detected 08/05 pt cc: cough, diarrhea, fatigue, fever, headache, myalgias, sore throat 08/06 pt cc: cough, fever, myalgias 08/07 pt cc: cough, fatigue, loss of taste or smell symptoms are improving 08/08 pt cc: cough, fatigue symptoms are improving 08/11 pt cc: bilateral leg numbness 08/11 ED admission with cc: tingling in her extremities and face, fatigue, malaise 08/12 SARS COV-2 LINEAGE result: AY.4 08/12 SARS-COV-2 CLADE result: 21A Delta
Age: 65.0
Sex: F
Vaccine: VARZOS
Symptoms: Unevaluable event
Clinical narrative: Narrative:
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: Narrative:
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Sedation
Clinical narrative: Sedation Narrative:
Age: 61.0
Sex: M
Vaccine: VARZOS
Symptoms: Pruritus, Rash
Clinical narrative: Narrative:  Patient reported rash and itching following administration of 1st dose of Shingrix vaccine. No interventions were reported.
Age: 0.17
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia oral, Throat tightness
Clinical narrative: cirucmoral numbness with throat tightness Narrative:
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Chromaturia, Confusional state, Cough
Clinical narrative: Narrative: 74y.o. MALE with a h/o 74 yo male: History of Alzheimer's, Parkinson's, dementia, iron deficiency anemia, polycythemia, diabetes neuropathy, hypertension, degenerative disc disease. Brought in by daughter on 8/10/2021 to ER dept. Over the last 6months, patient has been deteriorating with progression of disease, recently has been falling, more difficult to walk without assistance, more weak, and more confused. Patient lives with daughter and son-in-law. However, daughter has just been hospitalized with COVID and has been in quarantine, and son-in-law recently hurt back and is unable to care for patient. Neither are able to help pt perform ADL's, and they desire long-term placement at the skilled nursing facility. Daughter states pt has been been having darker urine from baseline recently, a non-productive cough, and has long-term left-sided weakness. On evaluation by medicine team, pt was not oriented to self, location, situation, and time/date. Pt is Covid+ and is fully covid vaccinated. Pt received vaccines on 1/20/21 & 2/19/2021. Pt was admitted and treated for covid infection with the following PLAN: - continue ceftriaxone 1g x5 days (8/9-8/13) - continue azithromycin 500 x3 days (8/10-8/12) - albuterol PRN, guiafenisin PRN Pt was covid positive after had been fully vaccinated. Pt was treated during this admission & discharged to nursing home placement on 9/2/2021.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Disease progression, Disorientation, Fall, Gait disturbance, General physical health deterioration
Clinical narrative: Narrative: 74y.o. MALE with a h/o 74 yo male: History of Alzheimer's, Parkinson's, dementia, iron deficiency anemia, polycythemia, diabetes neuropathy, hypertension, degenerative disc disease. Brought in by daughter on 8/10/2021 to ER dept. Over the last 6months, patient has been deteriorating with progression of disease, recently has been falling, more difficult to walk without assistance, more weak, and more confused. Patient lives with daughter and son-in-law. However, daughter has just been hospitalized with COVID and has been in quarantine, and son-in-law recently hurt back and is unable to care for patient. Neither are able to help pt perform ADL's, and they desire long-term placement at the skilled nursing facility. Daughter states pt has been been having darker urine from baseline recently, a non-productive cough, and has long-term left-sided weakness. On evaluation by medicine team, pt was not oriented to self, location, situation, and time/date. Pt is Covid+ and is fully covid vaccinated. Pt received vaccines on 1/20/21 & 2/19/2021. Pt was admitted and treated for covid infection with the following PLAN: - continue ceftriaxone 1g x5 days (8/9-8/13) - continue azithromycin 500 x3 days (8/10-8/12) - albuterol PRN, guiafenisin PRN Pt was covid positive after had been fully vaccinated. Pt was treated during this admission & discharged to nursing home placement on 9/2/2021.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Hemiparesis, Loss of personal independence in daily activities, SARS-CoV-2 test positive
Clinical narrative: Narrative: 74y.o. MALE with a h/o 74 yo male: History of Alzheimer's, Parkinson's, dementia, iron deficiency anemia, polycythemia, diabetes neuropathy, hypertension, degenerative disc disease. Brought in by daughter on 8/10/2021 to ER dept. Over the last 6months, patient has been deteriorating with progression of disease, recently has been falling, more difficult to walk without assistance, more weak, and more confused. Patient lives with daughter and son-in-law. However, daughter has just been hospitalized with COVID and has been in quarantine, and son-in-law recently hurt back and is unable to care for patient. Neither are able to help pt perform ADL's, and they desire long-term placement at the skilled nursing facility. Daughter states pt has been been having darker urine from baseline recently, a non-productive cough, and has long-term left-sided weakness. On evaluation by medicine team, pt was not oriented to self, location, situation, and time/date. Pt is Covid+ and is fully covid vaccinated. Pt received vaccines on 1/20/21 & 2/19/2021. Pt was admitted and treated for covid infection with the following PLAN: - continue ceftriaxone 1g x5 days (8/9-8/13) - continue azithromycin 500 x3 days (8/10-8/12) - albuterol PRN, guiafenisin PRN Pt was covid positive after had been fully vaccinated. Pt was treated during this admission & discharged to nursing home placement on 9/2/2021.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Colonoscopy, Cough, Oropharyngeal pain, Rhinorrhoea
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/26, Pfizer, dose #1 03/18, Pfizer, dose #2 07/29 Had colonoscopy (private sector) 08/01 pt  cc: cough non-productive, rhinorrhea, sore throat 08/02 seen private sector at clinic given rx z pak and medrol dose pak 08/03 pt cc: cough exposure: unknown 08/03 COVID swab, result: detected 08/05 cough, rhinorrhea, sore throat 08/06 pt cc: "cough and sneezes much better than the Saturday...still a little/slight cough states however feeling better" pt report: T97.5, bp 136/78, sat 98% 08/07 pt cc: rhinorrhea and post nasal drop (IMPROING) 08/08 clinically resolved
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Sneezing, Upper-airway cough syndrome
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/26, Pfizer, dose #1 03/18, Pfizer, dose #2 07/29 Had colonoscopy (private sector) 08/01 pt  cc: cough non-productive, rhinorrhea, sore throat 08/02 seen private sector at clinic given rx z pak and medrol dose pak 08/03 pt cc: cough exposure: unknown 08/03 COVID swab, result: detected 08/05 cough, rhinorrhea, sore throat 08/06 pt cc: "cough and sneezes much better than the Saturday...still a little/slight cough states however feeling better" pt report: T97.5, bp 136/78, sat 98% 08/07 pt cc: rhinorrhea and post nasal drop (IMPROING) 08/08 clinically resolved
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature increased, Chills, Fatigue, Headache, Injection site pain
Clinical narrative: Headache, elevated temp, fatigue, chills, injections site/local lymph node pain Narrative:
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain
Clinical narrative: Headache, elevated temp, fatigue, chills, injections site/local lymph node pain Narrative:
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chills, Cough, Fatigue, Myalgia
Clinical narrative: Narrative: COVID infection following COVID vaccine series 12/31/2020 , Moderna , dose #1 administered non-Facility 01/28 , Moderna , dose #2 administered non-Facility 08/10/2020 COVID swab result: not detected 06/25 pt cc: rhinorrhea, sore throat, fatigue, myalgia exposure; unknown 08/03 pt requesting COVD swab 08/04 COVID swab, result: detected 08/04 pt cc: chills, cough, rhinorrhea, fatigue, myalgia clinically resolved
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 12/31/2020 , Moderna , dose #1 administered non-Facility 01/28 , Moderna , dose #2 administered non-Facility 08/10/2020 COVID swab result: not detected 06/25 pt cc: rhinorrhea, sore throat, fatigue, myalgia exposure; unknown 08/03 pt requesting COVD swab 08/04 COVID swab, result: detected 08/04 pt cc: chills, cough, rhinorrhea, fatigue, myalgia clinically resolved
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Laboratory test, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: Narrative: 08/31/2020 COVID swab, result: not detected COVID infection following COVID vaccine series 01/28, Pfizer, dose#1 04/12, Pfizer, dose #2 administered non-facility 08/05 COVID swab, result: detected 08/05 pt cc; rhinorrhea exposure: unknown 08/05 SARS-COV-2 LINEAGE result: B.1.617.2 08/05 SARS-COV-2 clade result: 21A DELTA
Age: 74.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Unevaluable event
Clinical narrative: Narrative:
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chills, Cough, Diarrhoea, Fatigue
Clinical narrative: Narrative: COVID infection following COVID vaccine series 12/29, Pfizer, dose #1 01/19, Pfizer, dose #2 08/04 pt cc: chills, cough, diarrhea, fatigue, fever, headache, myalgias, rhinorrhea exposure: unknown 08/04 COVID swab, result: detected 08/04 - 08/09 pt continue to have symptoms 08/04 SARS-COV-2 Variant Sequencing results: pending 08/10 pt reports mild symptoms, clinically resolved
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Laboratory test, Malaise, Myalgia, Pyrexia
Clinical narrative: Narrative: COVID infection following COVID vaccine series 12/29, Pfizer, dose #1 01/19, Pfizer, dose #2 08/04 pt cc: chills, cough, diarrhea, fatigue, fever, headache, myalgias, rhinorrhea exposure: unknown 08/04 COVID swab, result: detected 08/04 - 08/09 pt continue to have symptoms 08/04 SARS-COV-2 Variant Sequencing results: pending 08/10 pt reports mild symptoms, clinically resolved
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 12/29, Pfizer, dose #1 01/19, Pfizer, dose #2 08/04 pt cc: chills, cough, diarrhea, fatigue, fever, headache, myalgias, rhinorrhea exposure: unknown 08/04 COVID swab, result: detected 08/04 - 08/09 pt continue to have symptoms 08/04 SARS-COV-2 Variant Sequencing results: pending 08/10 pt reports mild symptoms, clinically resolved
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Syncope
Clinical narrative: Narrative: Patient reported syncope after receiving 2nd dose of pfizer covid vaccine. States has syncope after any vaccine, blood draw, etc. Patient was able to depart without any intervention.
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoaesthesia
Clinical narrative: Narrative: Patient reported numbness following administration of Pfizer covid vaccine. Patient reported this occurred after first dose as well. Patient was released without any intervention.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/14, Pfizer, dose #2 02/04, Pfizer, dose #2 08/06 COVID swab, result: detected 08/06 pt cc: unknown exposure: unknown
Age: 59.0
Sex: M
Vaccine: PPV, VARZOS
Symptoms: Unevaluable event
Clinical narrative: Narrative:
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Dyspnoea, Exposure to SARS-CoV-2, Fatigue
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 10/14/2020 COVID swab, result: not detected 04/08 Janssen, dose #1 administered in non-agency 07/30 pt cc: cough, fatigue, fever, headache, myalgias 08/04 COVID swab, result: detected 08/05 pt cc: cough fatigue, myalgias dyspnea, sinus congestion exposure: recent trips 08/07 pt cc: cough and fatigue is improving 08/08 pt cc: cough and fatigue resolved 08/08 clinically resolved 08/12 SARS-COV-2 LINEAGE result: B.1.617.2 08/12 SARS-COV-2 clade result: 21 A (delta)
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Myalgia, Pyrexia, SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 10/14/2020 COVID swab, result: not detected 04/08 Janssen, dose #1 administered in non-agency 07/30 pt cc: cough, fatigue, fever, headache, myalgias 08/04 COVID swab, result: detected 08/05 pt cc: cough fatigue, myalgias dyspnea, sinus congestion exposure: recent trips 08/07 pt cc: cough and fatigue is improving 08/08 pt cc: cough and fatigue resolved 08/08 clinically resolved 08/12 SARS-COV-2 LINEAGE result: B.1.617.2 08/12 SARS-COV-2 clade result: 21 A (delta)
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Sinus congestion
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 10/14/2020 COVID swab, result: not detected 04/08 Janssen, dose #1 administered in non-agency 07/30 pt cc: cough, fatigue, fever, headache, myalgias 08/04 COVID swab, result: detected 08/05 pt cc: cough fatigue, myalgias dyspnea, sinus congestion exposure: recent trips 08/07 pt cc: cough and fatigue is improving 08/08 pt cc: cough and fatigue resolved 08/08 clinically resolved 08/12 SARS-COV-2 LINEAGE result: B.1.617.2 08/12 SARS-COV-2 clade result: 21 A (delta)
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Hypoxia, Pyrexia
Clinical narrative: Narrative: 76 yo male patient with hx of T2DM, Afib, HRrEF who presented with worsened hypoxia and dyspnea. Had a fever last week Patient fully vaccinated with Pfizer vaccine in March of 2021. Date of onset of symptoms determined to be around 8/26-27. Patient required 2-3L of supplemental oxygen and was initiated on Remdesivir and Dexamethasone.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Hepatic encephalopathy, Mental status changes, SARS-CoV-2 test positive
Clinical narrative: Narrative:  58y.o. MALE with a h/o HCC, alcoholic cirrhosis, depression, h/o PE, HTN, HLD, BPH, GERD and hyperglycemia who presented to the ED (on 9/2/21) for altered mental status. Of note, the patient was admitted last month for acute hepatic encephalopathy. The patient tested positive in the emergency room for covid today. Pt had received vaccines from a NON-AGENCY source documented in chart as given on 1/29/2021 & 2/19/2021. Pt with positive covid pneumonia admitted for Hepatic Encephalopathy exacerbated by covid positive pneumonia infection. Pt treated and discharged on 9/8/21.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Prostate cancer, Prostate cancer metastatic
Clinical narrative: Narrative:  72yo male pt died on 10/2/21 in home hospice care. Death caused by Progressive metastatic prostate cancer. Pt had received covid vaccines on 02/17/21 & 1/19/21. Death is not related to vaccines.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Narrative: Patient developed a rash following administration of pfizer covid vaccine. Patient was prescribed tramcinolone ointment to manage the rash.
Age: 66.0
Sex: M
Vaccine: PPV
Symptoms: Unevaluable event
Clinical narrative: Narrative:
Age: 60.0
Sex: M
Vaccine: FLUX
Symptoms: Unevaluable event
Clinical narrative: Narrative:
Age: 72.0
Sex: M
Vaccine: FLUX
Symptoms: Unevaluable event
Clinical narrative: Narrative:
Age: 91.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Asthenia, COVID-19, Cough, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: Narrative: 91 yo patient w/PMH significant for cardiomyopathy, hypertension, and hypothyroidism and s/p Pfizer COVID-19 vaccinations on 1/16/21 and 2/6/21 (21 days apart). Patient tested positive for COVID-19 on 3/23/21. Patient's daughter called the Facility requesting a COVID-19 test for patient after patient's wife tested positive for COVID-19. Per daughter, patient had a dry cough and runny nose starting 3/18/21. No treatment medications required, patient did not require hospitalization. Patient and daughter provided COVID-19 positive result and counseling by MD by phone on 3/25/21. Infection Control staff documented on 3/26/21 that case report and lab result faxed to Health Department + specimen collected 03/24/21. On 5/4/21, patient recently had a telephone general medicine clinic appt. MD documented: "says he is doing well other than just feels little weak. denies any fever/chills/chest apin/son. no abd pain/nausea/vomitting/diarrhea/malena. no urine problems.no leg edema.appetit ok.wt stable." On 10/20/21, patient received his 3rd pfizer COVID-19 vaccination without complications.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site discomfort
Clinical narrative: Narrative: Patient received 2nd Pfizer shot today. Reported discomfort to injection site. Patient was not in acute distress.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus, Rash, Rash erythematous
Clinical narrative: Narrative: 71 yo M Patient with PMH of thrombocytopenic disorder, large prostate, HLD, viral hep C, and HTN who developed a diffuse rash on upper arms, upper thighs, and buttocks after receiving the Pfizer COVID vaccine first dose. Patient reports that "There are little red bumps the size of 1-2 pinhead's light red in color, no pain, no fever, no sore throat, no cough, no contact with anything new other than Vaccine. Does not do any outdoor activities. Overall, itchiness is getting better." Patient was given hyrocortisone cream. Per 3/1/21 note, rash appears to be improving and provider advised to get the 2nd dose of the COVID vaccine.